Use access key #2 to skip to page content.
$10.27 -0.63 (-5.78%)
1/9/2009 4:00 PM

Alkermes, Inc. (ALKS)

CAPS Rating:
****

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

View All Commentary (ALKS)

Recs

0

Avatar mfly (69.02) Submitted: 3/30/07 4:11 PM : Outperform Start Price: $15.41 ALKS Score: 3.98

solid product direction, new product just now being adopted

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links